NMD Pharma begins first clinical trial: "Our entire team can be enormously proud"
Biotech firm NMD Pharma, which secured a DKK 280 million investment two years ago, is now ready to begin a clinical trial with its most promising candidate.
BY KEVIN GRØNNEMANN, TRANSLATED BY IDA JACOBSEN
Danish biotech company NMD Pharma is now taking one of the big leaps that any hopeful start-up company in the industry dreams of.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
